Dan W. Gladney - 22 Jul 2021 Form 4 Insider Report for ReShape Lifesciences Inc. (RSLS)

Role
Director
Signature
/s/Dan W. Gladney
Issuer symbol
RSLS
Transactions as of
22 Jul 2021
Net transactions value
-$598,000
Form type
4
Filing time
17 Sep 2021, 18:37:24 UTC
Previous filing
24 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RSLS Common Stock, $0.001 par value per share Award $0 +483,922 $0.000000 483,922 22 Jul 2021 Direct F1
transaction RSLS Common Stock, $0.001 par value per share Sale $598,000 -200,000 -41% $2.99 283,922 10 Sep 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares will vest and be issued with respect to 241,961 shares on each of July 22, 2021 and July 22, 2022 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
F2 A portion of these shares were sold to cover taxes in connection with the vesting of restricted stock units.